Cargando…
IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis
Anaplastic thyroid carcinomas (ATC) are rare, but represent the most lethal malignancy of the thyroid. Selective molecular markers and drivers distinguishing ATC from other thyroid carcinomas of follicular origin remain largely unknown, limiting advances in diagnosis and treatment. In a retrospectiv...
Autores principales: | Haase, Jacob, Misiak, Danny, Bauer, Marcus, Pazaitis, Nikolaos, Braun, Juliane, Pötschke, Rebecca, Mensch, Alexander, Bell, Jessica Lilian, Dralle, Henning, Siebolts, Udo, Wickenhauser, Claudia, Lorenz, Kerstin, Hüttelmaier, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806508/ https://www.ncbi.nlm.nih.gov/pubmed/32719445 http://dx.doi.org/10.1038/s41379-020-0630-0 |
Ejemplares similares
-
MiRNA Deregulation Distinguishes Anaplastic Thyroid Carcinoma (ATC) and Supports Upregulation of Oncogene Expression
por: Misiak, Danny, et al.
Publicado: (2021) -
IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer
por: Bley, Nadine, et al.
Publicado: (2020) -
IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG)
por: Zirkel, Anne, et al.
Publicado: (2013) -
IGF2BP1 Promotes Proliferation of Neuroendocrine Neoplasms by Post-Transcriptional Enhancement of EZH2
por: Sperling, Florian, et al.
Publicado: (2022) -
IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer
por: Glaß, Markus, et al.
Publicado: (2021)